Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06357234
PHASE2

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

Sponsor: IWK Health Centre

View on ClinicalTrials.gov

Summary

This research trial will measure how useful Aprepitant is in preventing nausea and vomiting in children having surgery to correct scoliosis (curvature of the spine).

Official title: A Randomized Controlled Trial Comparing Aprepitant to Standard of Care for Postoperative Nausea and Vomiting Prophylaxis in Children and Adolescents Undergoing Scoliosis Surgery: The APRE-PONV Trial

Key Details

Gender

All

Age Range

8 Years - 19 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-03-17

Completion Date

2027-09

Last Updated

2025-03-25

Healthy Volunteers

No

Interventions

DRUG

Aprepitant

Two doses of 40mg (2ml) Aprepitant. One to be given on the morning of surgery and the second on the morning of post-op day 1

DRUG

Placebo

Two doses of dextrose syrup (2ml). One to be given on the morning of surgery and the second on the morning of post-op day 1

Locations (1)

IWK Health Sciences Center

Halifax, Nova Scotia, Canada